The resulting albumin-coated polyplexes were shown to decrease expression of the PD-L1 gene in CT26 colorectal cancer cells, reducing PD-L1 protein levels by more than 6-fold compared to treatment with a complex of Lipofectamine and genome-editing components. Here, CD274 is linked to colorectal cancer.